Clinical trial
Study Comparing Desirudin With Heparin to Prevent Vein Clots After Heart and…
NCT00329433 · Washington University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00329433 |
|---|---|
| Title | Study Comparing Desirudin With Heparin to Prevent Vein Clots After Heart and Lung Surgery |
| Official title | The Use of Desirudin Versus Heparin for Thrombosis Prophylaxis in Cardiothoracic Surgery Patients |
| Lead sponsor | Washington University School of Medicine, Other |
| Collaborators | Barnes-Jewish Hospital Canyon Pharmaceuticals, Inc. Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Deep Venous Thrombosis |
| Intervention type | Drug |
| Interventions | Desirudin (Iprivask™), Heparin |
| Enrollment | 120 |
| Start date | May 1, 2006 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | May 24, 2006 |
| Last update posted | Mar 5, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: